![Charles Baum](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Baum
Director/Board Member at
PMV PHARMACEUTICALS, INC.
Net worth: 16 671 $ as of 2026-06-29
Profile
Dr. Charles M. Baum is a Chairman at Oncomyx Therapeutics, Inc. and a President, Chief Executive Officer & Director at Mirati Therapeutics, Inc. He is on the Board of Directors at PMV Pharmaceuticals, Inc., BCTG Acquisition Corp. and Mirati Therapeutics, Inc. Dr. Baum was previously employed as an Independent Director by Immunomedics, Inc., an Independent Director by Array BioPharma, Inc., and a Senior VP-Biotherapeutic Clinical Research by Pfizer Inc. He received his doctorate degree from Washington University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-16 | 9,366 ( 0.02% ) | 16 671 $ | 2026-06-29 | |
| 2026-06-03 | 0 ( -.--% ) | - $ | 2026-06-29 |
Charles Baum active positions
| Companies | Position | Start |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Director/Board Member | 2021-03-31 |
| ACRIVON THERAPEUTICS, INC. | Director/Board Member | 2023-06-21 |
Oncomyx Therapeutics, Inc.
 Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and operates software platform to orchestrate an immune response & treat cancer | Chairman | 2020-11-05 |
Terremoto Biosciences, Inc.
 Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Chief Executive Officer | 2024-07-24 |
Crossbow Therapeutics, Inc.
 Crossbow Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops antibodies for cancer treatment | Director/Board Member | - |
Former positions of Charles Baum
| Companies | Position | End |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Director/Board Member | 2025-01-07 |
| MIRATI THERAPEUTICS | Chief Executive Officer | 2024-01-22 |
| TANGO THERAPEUTICS, INC. | Director/Board Member | 2020-12-31 |
| IMMUNOMEDICS, INC. | Director/Board Member | 2020-10-22 |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Charles Baum
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
70
1st degree connections
13
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 13 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Washington University School of Medicine
 Washington University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PMV Pharmaceuticals, Inc.
 PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Poseida Therapeutics, Inc.
 Poseida Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops next generation cell and gene therapeutics | Health Technology |
Oncomyx Therapeutics, Inc.
Oncomyx Therapeutics, Inc. Packaged SoftwareTechnology Services Develops and operates software platform to orchestrate an immune response & treat cancer | Technology Services |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Odyssey Therapeutics, Inc.
 Odyssey Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for autoimmune and inflammatory diseases | Health Technology |
BCTG Acquisition Corp.
 BCTG Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company which develops drugs for oncology and genetic diseases | Health Technology |
Crossbow Therapeutics, Inc.
Crossbow Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops antibodies for cancer treatment | Health Technology |
- Stock Market
- Insiders
- Charles Baum
